Withaferin a attenuates epithelial-mesenchymal transition and cancer stem cells properties in hepatocellular carcinoma cells by inhibiting the PI3K/AKT pathway through miR-200c
Withaferin a attenuates epithelial-mesenchymal transition and cancer stem cells properties in hepatocellular carcinoma cells by inhibiting the PI3K/AKT pathway through miR-200c. Pharmacognosy Magazine [Internet]. 2022;18(80):1190-1195. http://www.phcog.com/text.asp?2022/18/80/1190/361785
.